FDA Reorganization of The Center for Devices and Radiological Health

The FDA’s Center for Devices and Radiological Health (CDRH) is reorganizing by integrating premarket and postmarket program functions along product lines, allowing FDA experts to leverage their knowledge to optimize decision-making across the product life cycle.

This is good news for the industry as it will ensure better communication among CDRH personnel working on the same product.

Read the recent update from the FDA.

Contact Vesna Janic, StarFish Medical Director of QA/RA, for information and advice on how this may impact your medical device submissions.

Join over 6000 medical device professionals who receive our engineering, regulatory and commercialization insights and tips every month.